CHCT Returns to Profitability in Q2 but Slashes Dividend 31% to Fuel $99M Acquisition Pipeline
CHCT sits 29% above its 52-week low of $13.23 on elevated volume (2.6× avg).
Summary
CHCT posted a Q2 profit of $2.4M versus a year-ago loss, but slashed its dividend 31% to fund a $99M acquisition pipeline. Interest costs are rising after swap expirations, and a $300M ATM program remains available.
Updates
· SEC 8-K — The 8-K includes a Strategic Plan Presentation targeting 92% occupancy, 9-12% reinvestment yields, over $70M of marketed dispositions, and a $99M acquisition pipeline with 9-10% expected yields and ~2.5% escalators.
Key Events · Earnings and Guidance · CHCT
-
Q2 Profit Recovery
Net income reached $2.4M ($0.06/share), a sharp reversal from the $12.6M loss (-$0.50) in Q2 2025, driven by a $5.7M drop in G&A expenses and the absence of the prior year's $8.7M credit loss reserve.
-
Dividend Slashed 31%
The quarterly dividend was cut to $0.33 from $0.48, a move that will retain $25–$30M annually to fund a $99M acquisition pipeline of four properties expected to close through 2027.
-
Rising Interest Costs
Interest expense rose 12.7% to $7.4M after $75M of interest rate swaps matured in March 2026, leaving that portion of the revolver exposed to a floating rate of ~5.3%.
-
Acquisition Pipeline Funded Internally
Four properties are under contract for $99M, with closings expected from Q3 2026 through 2027. Funding will come from retained cash flow, debt, or asset sales—no equity issuance is planned near-term.
Analysis · CHCT · Real Estate & Construction
Community Healthcare Trust swung back to profitability in Q2 2026, posting net income of $2.4 million compared with a $12.6 million loss a year earlier. The turnaround was fueled by a sharp decline in general and administrative costs—last year's quarter included executive severance and a credit loss reserve that did not recur. However, the headline is the 31% dividend reduction to $0.33 per share, a move designed to retain $25–$30 million annually for a $99 million acquisition pipeline. That decision signals a clear strategic pivot: management is prioritizing growth over near-term shareholder payouts. Adding pressure, interest expense is creeping higher after $75 million of swaps matured, leaving that portion of the revolver exposed to floating rates. The balance sheet shows $285 million drawn on the revolver with $115 million available, while a $300 million ATM program sits untouched—a potential dilution overhang if tapped. The portfolio remains 89.8% leased with a 7.2-year weighted average lease term, offering some stability, but the shift to self-funding acquisitions through retained cash flow marks a change investors will need to digest.
How filings like this one have moved
In the 30 days to Oct 3, 2026, 36.5% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.60%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CHCT was trading at $17.07 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $506M. The 52-week trading range was $13.23 to $19.17. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.